Filter by
Filter by
A Pilot Trial of Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable Non-Small Cell Lung Cancer with Extended Durvalumab Therapy (PARTICLE-D).
This phase I dose-escalation study by the group of Cleveland Medical Center, Ohio, reported severe treatment related toxicity. A total of 7 patients with stage...
Clinical practice in European centres treating paediatric posterior fossa tumours with pencil beam scanning proton therapy.
Published in the Green Journal, this survey study sent to 19 European PT centers revealed wide variations in planning approach and consequently dose to organs...
Quantifying dose uncertainties resulting from cardiorespiratory motion in intensity-modulated proton therapy for cardiac stereotactic body radiotherapy.
This study from China investigated dose uncertainties induced by cardiorespiratory motion in proton therapy for arrhythmia. Twelve patients with refractory...